Acid-Base Compensation in Chronic Kidney Disease
NCT02427594 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2017-08-30
Summary
The purpose of this study is to evaluate changes in urine net acid excretion, blood pressure and body chemistry that occur when the dietary acid load is lowered by using a drug/dietary supplement similar to baking soda. This may be important for patients with kidney disease because they may have difficulty removing all of the dietary acid load from the body in the urine. Participants with and without kidney disease will be recruited. Each participant will be fed a controlled diet for one week with sodium bicarbonate and for one week without sodium bicarbonate to evaluate these changes. The investigators will also determine if the effect of dietary acid load reduction is different in patients with kidney disease compared to those without kidney disease.
Conditions
Interventions
- DRUG
-
Sodium bicarbonate
Drug/dietary supplement is used in a crossover design to lower the nonvolatile acid load of the diet compared to the control period.
- OTHER
-
Controlled diet
Diet without sodium bicarbonate supplementation
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH - lead OTHER
Principal Investigators
-
Julia Scialla · Duke University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2017-08-25
- Completion
- 2017-08-25
Countries
- United States
Study Locations
More Related Trials
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
NCT04984226 ·Status: RECRUITING ·Phase: PHASE2
-
Sympatholysis in Chronic Kidney Disease
NCT02411773 ·Status: RECRUITING ·Phase: PHASE1
-
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
NCT00579995 ·Status: TERMINATED ·Phase: NA
-
Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)
NCT00514150 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
NCT00424320 ·Status: UNKNOWN ·Phase: PHASE3
-
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
NCT01172353 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
NCT00353340 ·Status: COMPLETED ·Phase: NA
-
Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
NCT01218178 ·Status: COMPLETED
-
The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy
NCT00494637 ·Status: TERMINATED ·Phase: NA
-
Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate
NCT00540904 ·Status: COMPLETED ·Phase: PHASE2
-
Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
NCT00312117 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
NCT00498342 ·Status: COMPLETED ·Phase: NA
-
Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
NCT00716001 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
NCT00950079 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
NCT01232257 ·Status: COMPLETED ·Phase: PHASE3
-
Sodium Bicarbonate in Preventing Contrast Induced Nephropathy
NCT00531765 ·Status: COMPLETED ·Phase: NA
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED
NCT00501475 ·Status: UNKNOWN ·Phase: PHASE4
-
Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN
NCT00513825 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Sodium Bicarbonate As Prophylaxis for Kidney Damage in Patients with Heatstroke
NCT06622525 ·Status: RECRUITING ·Phase: NA
-
Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease
NCT00506506 ·Status: COMPLETED ·Phase: PHASE3
-
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
NCT00606827 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
NCT01210456 ·Status: UNKNOWN ·Phase: PHASE3
-
Early Hydration in Acute Myocardial Infarction
NCT01742130 ·Status: COMPLETED ·Phase: PHASE4